Danielvettori4421 Jan, 2025Business
Medtech innovation often faces a paradox: balancing the need for groundbreaking technologies with the constraints of efficiency and profitability. This challenge was the focal point of Duke Rohlen’s keynote, The Middle Path to Innovation, presented at LSI Europe ’25. Drawing from his thesis published in the Harvard Business Review, Rohlen, the Founder, CEO, and Chairman of Ajax Health, introduced the growth driver framework—a strategy for developing high-growth medtech products within slow-growth companies. Alongside Mano Iyer of Sofinnova Partners, Rohlen outlined a transformative approach for medtech entrepreneurs and investors navigating an increasingly complex landscape.
Kèo Nhà Cái Hôm Nay
Twin68
Johnathan Rhyne, Jr.
Front Desk
Piano Academy Of Ireland
Win999itcom
Onehope It Solution
Aaria Tees
Uu88
Ariel Printing - Printing Adelaide